Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
5.21
0.35 (7.20%)
At close: Sep 26, 2025, 10:58 AM
7.20% (1D)
| Bid | 5.18 |
| Market Cap | 446.35M |
| Revenue (ttm) | 482K |
| Net Income (ttm) | -99.79M |
| EPS (ttm) | -1.57 |
| PE Ratio (ttm) | -3.32 |
| Forward PE | -2.95 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.24 |
| Volume | 1,219,885 |
| Avg. Volume (20D) | 1,520,453 |
| Open | 4.92 |
| Previous Close | 4.86 |
| Day's Range | 4.89 - 5.29 |
| 52-Week Range | 1.61 - 9.50 |
| Beta | 0.92 |
| Ex-Dividend Date | n/a |
About LRMR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LRMR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LRMR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-3.02%
Larimar Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
9 months ago
-21.72%
Larimar Therapeutics shares are trading lower after the company reported initial data from its ongoing OLE rare disease drug study.
